- Home
- CYTH vs AMS Comparison
CYTH vs AMS Comparison
Compare CYTH & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTH
- AMS
- Stock Information
- Founded
- CYTH 1990
- AMS 1980
- Country
- CYTH United States
- AMS United States
- Employees
- CYTH N/A
- AMS N/A
- Industry
- CYTH Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- CYTH Health Care
- AMS Health Care
- Exchange
- CYTH Nasdaq
- AMS Nasdaq
- Market Cap
- CYTH 26.2M
- AMS 21.1M
- IPO Year
- CYTH N/A
- AMS N/A
- Fundamental
- Price
- CYTH $0.80
- AMS $3.19
- Analyst Decision
- CYTH Buy
- AMS
- Analyst Count
- CYTH 3
- AMS 0
- Target Price
- CYTH $0.95
- AMS N/A
- AVG Volume (30 Days)
- CYTH 52.2K
- AMS 12.4K
- Earning Date
- CYTH 03-17-2025
- AMS 11-13-2024
- Dividend Yield
- CYTH N/A
- AMS N/A
- EPS Growth
- CYTH N/A
- AMS 779.12
- EPS
- CYTH N/A
- AMS 0.61
- Revenue
- CYTH $870,725.00
- AMS $24,969,000.00
- Revenue This Year
- CYTH N/A
- AMS $27.74
- Revenue Next Year
- CYTH $24.49
- AMS $17.72
- P/E Ratio
- CYTH N/A
- AMS $5.33
- Revenue Growth
- CYTH N/A
- AMS 20.83
- 52 Week Low
- CYTH $0.55
- AMS $2.51
- 52 Week High
- CYTH $2.12
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- CYTH 70.05
- AMS 51.40
- Support Level
- CYTH $0.76
- AMS $3.03
- Resistance Level
- CYTH $0.86
- AMS $3.26
- Average True Range (ATR)
- CYTH 0.07
- AMS 0.11
- MACD
- CYTH 0.03
- AMS 0.01
- Stochastic Oscillator
- CYTH 92.58
- AMS 47.22
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.